High-risk biochemical recurrence in prostate cancer: identification and early intervention strategies
This narrative, evidence-supported expert-opinion review highlights the importance of standardized protocols, multidisciplinary strategies, and the integration of advanced diagnostics and androgen receptor pathway inhibitors to improve patient outcomes. Further research is warranted to refine predictive models, optimize resource allocation, and enhance therapeutic efficacy.
Authors
- Mai Mohamed Ali Ezz El Din
- Emad Hamada
- Mohamed Abdullah (ORCID: https://orcid.org/0000-0003-0714-7139)
- Tarek Osman (ORCID: https://orcid.org/0000-0002-3835-7369)
- Ahmed Hassan Abdelaziz
- A. Nowier
- M. Sherif Mourad
- Dina Salah Gad
- Hassan Sayed Shaker
Institutions
- Ain Shams University (EG)
- Cairo University (EG)
Publication Details
- Journal
- Frontiers in Urology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.3389/fruro.2026.1719136
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Astellas Pharma